Market Overview

15 Biggest Mid-Day Losers For Monday

  • Vince Holding Corp (NYSE: VNCE) shares dipped 25 percent to $0.975. Vince reported a delay in fiscal 2016 10-K filing.
  • Skyline Corporation (NYSE: SKY) shares tumbled 23.8 percent to $6.44. Skyline posted a Q3 net loss of $2,447,000, or $0.29 per share, versus year-ago net loss of $520,000 or $0.06 per share.
  • Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares dropped 18.7 percent to $3.88 as the company disclosed that its Phase 2 trial of tarextumab did not meet endpoints. OncoMed also reported that it will discontinue enrollment in Phase 1B clinical trial of brontictuzumab.
  • Snyder's-Lance Inc (NASDAQ: LNCE) shares fell 18.5 percent to $32.55. Snyder's-Lance announced the retirement of its CEO and issued a weak forecast.
  • Immune Pharmaceuticals Inc (NASDAQ: IMNP) shares dropped 11.8 percent to $2.25 after declining 2.67 percent on Thursday.
  • Apricus Biosciences Inc (NASDAQ: APRI) shares dropped 11.3 percent to $1.72. Apricus Biosciences filed for offering of up to $6 million of units.
  • China Auto Logistics Inc (NASDAQ: CALI) shares fell 11.1 percent to $2.66.
  • Incyte Corporation (NASDAQ: INCY) dropped 11 percent to $125.34. The FDA on Friday declined to approve Eli Lilly and Co and Incyte arthritis drug Olumiant. PiperJaffray downgraded Incyte from Overweight to Neutral.
  • Timkensteel Corp (NYSE: TMST) declined 10.9 percent to $15.77. TimkenSteel projects Q1 net sales of around $309 million on 280,000 ship tons and a net loss of around $5 million.
  • Biostar Pharmaceuticals Inc (NASDAQ: BSPM) shares dropped 10.8 percent to $2.03. Biostar Pharmaceuticals reported a FY16 net loss of $5.7 million on sales of $2.4 million.
  • Adeptus Health Inc (NYSE: ADPT) shares declined 9.8 percent to $2.11.
  • Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) fell 9.6 percent to $14.48. Chardan Capital reiterated Akari Therapeutics with a Sell and raised the price target from $5.00 to $6.50.
  • GWG Holdings Inc (NASDAQ: GWGH) shares declined 9 percent to $9.60 after dropping 5.62 percent on Thursday.
  • SemiLEDs Corporation (NASDAQ: LEDS) shares dropped 8.6 percent to $2.87.
  • Eli Lilly and Co (NYSE: LLY) fell 4.1 percent to $82.39. The FDA on Friday declined to approve Eli Lilly and Incyte arthritis drug Olumiant. BMO Capital downgraded Eli Lilly from Market Perform to Underperform.

Related Articles (ADPT + AKTX)

View Comments and Join the Discussion!

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings

Latest Ratings

MRTXHC Wainwright & Co.Maintains257.0
NVDATruist SecuritiesMaintains672.0
BLKBMO CapitalMaintains715.0
BLKDeutsche BankMaintains838.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at